Fludarabine metabolite level on day zero does not affect outcomes of hematopoietic cell transplantation in patients with normal renal function

Bone Marrow Transplant. 2014 Apr;49(4):589-91. doi: 10.1038/bmt.2013.234. Epub 2014 Jan 27.

Authors

C D Griffiths¹, E S M Ng¹, S B Kangarloo¹, T S Williamson¹, M A Chaudhry¹, R Booker¹, P Duggan¹, P Yue¹, L Savoie¹, C Brown¹, N Cox-Kennett¹, J A Russell¹, A Daly¹, J Storek¹

Affiliation

¹ Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.

PMID: 24464143
DOI: 10.1038/bmt.2013.234

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Hematopoietic Stem Cell Transplantation / methods*
Humans
Kidney / metabolism
Multivariate Analysis
Transplantation Conditioning / methods*
Treatment Outcome
Vidarabine / analogs & derivatives*
Vidarabine / blood
Vidarabine / pharmacokinetics

Substances

Vidarabine
fludarabine